Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
22 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/22/3065281/0/en/R3-Vascular-Announces-First-Patient-Treated-in-ELITE-BTK-Pivotal-Trial-for-Below-the-Knee-PAD-Using-MAGNITUDE-Drug-Eluting-Bioresorbable-Scaffold.html
04 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/04/2973818/0/en/FDA-Grants-R3-Vascular-IDE-Approval-for-ELITE-BTK-Pivotal-Trial-of-its-MAGNITUDE-Drug-Eluting-Next-Generation-Bioresorbable-Scaffold-for-Below-the-Knee-Peripheral-Arterial-Disease.html
09 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/07/09/2910677/0/en/R3-Vascular-Appoints-Josh-Smale-as-its-Vice-President-of-Global-Clinical-and-Scientific-Affairs.html
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879009/0/en/R3-Vascular-Announces-87-Million-in-Series-B-Financing-and-Appoints-Christopher-M-Owens-as-new-President-and-CEO.html
ABOUT THIS PAGE